drugset / Trial / NCT02091180

Mannitol Improves Cerebral Oxygen Saturation

NCT02091180

Phase 4 Completed 40 enrolled Imam Abdulrahman Bin Faisal University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Decreased cerebral oxygen saturation (rSO2) was reported to occur during insufflation for laparoscopic procedures due to increased Intracranial pressure (ICP) with resultant decrease in cerebral perfusion pressure.

Timeline

Start
2013-01
Primary completion
2013-11
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Mannitol Diagnostic / imaging agent 0.5 g/kg Intravenous

Indications

No indication recorded.